Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act - Barron's

Fecha de publicación: 3 de noviembre de 2026, 18:55

Pfizer Bets on Cancer and Weight-Loss Drugs in Post-Pandemic Second Act Barron's Pfizer hikes full-year outlook as newer products grow, taps company veteran as new CFO CNBC Pfizer increases annual profit forecast amid solid demand for blood thinner drug Yahoo Finance Pfizer raises 2026 forecasts as…